amikacine fresenius kabi 5 mg/ml inf. sol. i.v. vial
fresenius kabi sa-nv - amikacin sulfate 6,68 mg/ml - eq. amikacin 5 mg/ml - solution for infusion - 5 mg/ml - amikacin sulfate 6.68 mg/ml - amikacin
amikacine fresenius kabi 5 mg/ml inf. sol. i.v. vial
fresenius kabi sa-nv - amikacin sulfate 6,68 mg/ml - eq. amikacin 5 mg/ml - solution for infusion - 5 mg/ml - amikacin sulfate 6.68 mg/ml - amikacin
amikacine fresenius kabi 5 mg/ml inf. sol. i.v. vial
fresenius kabi sa-nv - amikacin sulfate 6,68 mg/ml - eq. amikacin 5 mg/ml - solution for infusion - 5 mg/ml - amikacin sulfate 6.68 mg/ml - amikacin
amikacin 5 mg/ml solution for infusion
fresenius kabi deutschland gmbh - amikacin - solution for infusion - 5 milligram(s)/millilitre - other aminoglycosides; amikacin
amikacin sulfate injection, solution
fresenius kabi usa, llc - amikacin sulfate (unii: n6m33094fd) (amikacin - unii:84319sgc3c) - amikacin 250 mg in 1 ml - amikacin sulfate injection, usp is indicated in the short-term treatment of serious infections due to susceptible strains of gram-negative bacteria, including pseudomonas species, escherichia coli , species of indole-positive and indole-negative proteus , providencia species, klebsiella species, enterobacter species, serratia species, and acinetobacter species. to reduce the development of drug-resistant bacteria and maintain the effectiveness of amikacin and other antibacterial drugs, amikacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. a history of hypersensitivity to amikacin is a contraindication for its use. a history of hypersensitivity or serious toxic react
amikacin 100 mg/2ml fresenius injection
fresenius kabi manufacturing sa (pty) ltd - injection - see ingredients - each 2 ml vial contains amikacin sulphate equivalent to 100 mg amikacin
amikacin 500 mg/2ml fresenius injection
fresenius kabi manufacturing sa (pty) ltd - injection - see ingredients - each 2 ml vial contains amikacin sulphate equivalent to 500 mg amikacin
amikacin 1 g/4 ml fresenius injection
fresenius kabi manufacturing sa (pty) ltd - injection - see ingredients - each 4 ml solution contains amikacin sulphate equivalent to 1 g amikacin
amikacin - fresenius 1g/4ml
fresenius kabi manufacturing (sa) (pty) ltd - amikacin sulphate - injection - each 4ml of solution contains:amikacin sulphate equivalent to amikacin 1g
amikacin - fresenius 100mg/2ml
fresenius kabi manufacturing (sa) (pty) ltd - amikacin sulphate - injection - each 2ml of vial contains:amikacin sulphate equivalent to amikacin 100 mg